Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Syariah Indonesia Tbk (BRIS) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Bank Syariah Indonesia TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Syariah Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Syariah Indonesia Tbk trades at Rp1,730 (market cap 79.23T, 9.56M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bank Syariah Indonesia Tbk is far larger — about 255× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Syariah Indonesia Tbk is more actively traded (9.56M versus 963.6K). Which is the better fit depends on your goals.

BRISDGNS
Market Cap
79.23T310.75B
Volume
9.56M963.6K
Lot
95.64K9.64K
Turnover
16.64B217.67M
Average Price
1,740225.89
Value
16.64B217.67M
Indicative Equilibrium Price
1,730226
Indicative Equilibrium Volume
9.17K1K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BRIS
View details
DGNS
View details

About Bank Syariah Indonesia Tbk

PT Bank BRISyariah Tbk (the Bank) is located in Jakarta, Indonesia, and initially established under the name of PT Bank Jasa Arta (BJA) based on the Deed of Establishment No. 4 dated April 3, 1969 of Liem Toeng Kie, S.H., Notary in Jakarta.

Read more on BRIS

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS